Oxaprozin

Product NDC: 57664-391
11-digit product format: 576640391
Labeler code: 57664
Product ID: 57664-391_42a465c9-3cca-49aa-95bf-2658b3437218
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Oxaprozin
Dosage form: TABLET
Route: ORAL
Labeler: Caraco Pharmaceutical Laboratories, Ltd.
Application: ANDA075844
Marketing category: ANDA
Marketing start: 2002-01-03
Marketing end: 0000-00-00
Substance: OXAPROZIN
Active strength: 600 mg/1
Pharmacologic classes: Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	57664-391		D	Discontinued by firm	2026-08-03
excluded package	package	57664-391	57664-391-08	D	Discontinued by firm	2026-08-03
excluded package	package	57664-391	57664-391-13	D	Discontinued by firm	2026-08-03
excluded package	package	57664-391	57664-391-18	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	57664-391-08	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	57664-391-18	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	57664-391-13	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	57664-391-08	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	57664-391-18	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	57664-391-13	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	57664-391-08	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	57664-391-18	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	57664-391-13	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	57664-391-08	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	57664-391-18	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	57664-391-13	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	57664-391-08	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	57664-391-18	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	57664-391-13	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	57664-391-08	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	57664-391-18	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	57664-391-13	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	57664-391-08	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	57664-391-18	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	57664-391-13	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	57664-391-08	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	57664-391-18	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	57664-391-13	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	57664-391-08	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	57664-391-18	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	57664-391-13	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	57664-391-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	57664-391-18	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	57664-391-13	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	57664-391-08	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	57664-391-18	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	57664-391-13	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	57664-391-08	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	57664-391-18	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	57664-391-13	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A075844-001	OXAPROZIN	OXAPROZIN	600MG	TABLET / ORAL			2002-01-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A075844-001	OXAPROZIN	600MG	TABLET / ORAL	AB	2002-01-03	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A075844-001	OXAPROZIN	600MG	TABLET / ORAL	AB	2002-01-03	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A075844-001	OXAPROZIN	600MG	TABLET / ORAL		2002-01-03	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-09-15 20:21 UTC	2019-09	A075844-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A075844-001	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
95b4bbb5-24e2-44a4-b351-d64e35d6e76a	Product name	1	20250722
486cfca4-efa2-1446-eef2-3c74b667bb18	Product name	2	20170713

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
57664-391-08	EA - Each	57664-391	3f0a4a7e-1e98-4287-bc19-80fed57e1f3f	1	2013-02-13
57664-391-13	EA - Each	57664-391	36434924-3cbc-4330-af86-799751fd43e7	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Oxaprozin	ACTIVE INGREDIENT	MHJ80W9LRB	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
Oxaprozin	ACTIVE MOIETY	MHJ80W9LRB	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
METHYLCELLULOSE (400 MPA.S)	INACTIVE INGREDIENT	O0GN6F9B2Y	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OXAPROZIN TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]	2
OXAPROZIN	ACTIVE INGREDIENT	MHJ80W9LRB	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
OXAPROZIN	ACTIVE INGREDIENT	MHJ80W9LRB	OXAPROZIN TABLET [DIRECT RX]	1
OXAPROZIN	ACTIVE MOIETY	MHJ80W9LRB	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
OXAPROZIN	ACTIVE MOIETY	MHJ80W9LRB	OXAPROZIN TABLET [DIRECT RX]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	OXAPROZIN TABLET [DIRECT RX]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OXAPROZIN TABLET [DIRECT RX]	1
METHYLCELLULOSE (100 CPS)	INACTIVE INGREDIENT	4GFU244C4J	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
METHYLCELLULOSE (400 MPA.S)	INACTIVE INGREDIENT	O0GN6F9B2Y	OXAPROZIN TABLET [DIRECT RX]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	OXAPROZIN TABLET [DIRECT RX]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	OXAPROZIN TABLET [DIRECT RX]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	OXAPROZIN TABLET [DIRECT RX]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	OXAPROZIN TABLET [DIRECT RX]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OXAPROZIN TABLET [PHYSICIANS TOTAL CARE, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OXAPROZIN TABLET [DIRECT RX]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
MHJ80W9LRB	OXAPROZIN	21256-18-8	OXAPROZIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312132	oxaprozin 600 MG Oral Tablet	PSN	53d958ba-7a60-461b-8622-b73831a00725	3
312132	oxaprozin 600 MG Oral Tablet	SCD	53d958ba-7a60-461b-8622-b73831a00725	3
312132	oxaprozin 600 MG (as oxaprozin potassium 678 MG) Oral Tablet	SY	53d958ba-7a60-461b-8622-b73831a00725	3
312132	oxaprozin 600 MG Oral Tablet	PSN	18c897d3-47c2-461a-a0e7-0926453d45e3	1
312132	oxaprozin 600 MG Oral Tablet	SCD	18c897d3-47c2-461a-a0e7-0926453d45e3	1
312132	oxaprozin 600 MG (as oxaprozin potassium 678 MG) Oral Tablet	SY	18c897d3-47c2-461a-a0e7-0926453d45e3	1

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
OXAPROZIN	DIRECT RX	2019-04-19	HUMAN PRESCRIPTION DRUG LABEL	3
Oxaprozin - Caraco Pharmaceutical Laboratories, Ltd.	Caraco Pharmaceutical Laboratories, Ltd.	2013-03-08	Human Prescription Drug Label	2
Oxaprozin - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2009-12-30	HUMAN PRESCRIPTION DRUG LABEL	1